Kevin Johnson

Fondateur chez Medicxi Ventures (Jersey) Ltd.

Profil

Kevin Stuart Johnson is the founder of Inhibitaxin Ltd., founded in 2013, where the title held is Director.
Dr. Johnson is the founder of Medicxi Ventures (Jersey) Ltd., founded in 2016, where the title held is Senior Advisor.
Current jobs include Executive Chairman at Levicept Ltd., Director at Morphogen-IX Ltd. since 2015, Director at Impact Biomedicines, Inc., and Director at Rebalance (Cambridge) Ltd. since 2016.
Former jobs include Chief Executive Officer at PanGenetics BV, Chairman at Diartis Pharmaceuticals, Inc., Director at Aegerion Pharmaceuticals, Inc., Acutus Medical, Inc., Molecular Partners AG, Stealthyx Therapeutics Ltd., Versartis, Inc., Capella Bioscience Ltd., ApcinteX Ltd., SuperX Ltd., UltraHuman Ltd., Principal at MedImmune Ltd., Principal at the University of Melbourne, Principal at the University of Cambridge, and Partner at Index Ventures (UK) LLP from 2010 to 2016.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from The University of Edinburgh.

Postes actifs de Kevin Johnson

Sociétés	Poste	Début
Levicept Ltd.	Président	-
Medicxi Ventures (Jersey) Ltd.	Fondateur	01/01/2016
Inhibitaxin Ltd.	Fondateur	01/01/2013
Impact Biomedicines, Inc.	Directeur/Membre du Conseil	-
Morphogen-IX Ltd.	Directeur/Membre du Conseil	30/10/2015
Rebalance (Cambridge) Ltd.	Directeur/Membre du Conseil	06/12/2016

Anciens postes connus de Kevin Johnson

Sociétés	Poste	Fin
UltraHuman Ltd.	Directeur/Membre du Conseil	09/02/2022
ApcinteX Ltd.	Directeur/Membre du Conseil	29/01/2021
Index Ventures (UK) LLP	Private Equity Investor	31/01/2016
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-